This outcome corroborates that of previous studies showing that KRAS is among the most commonly mutated genes in pancreatic cancer, with a mutation frequency of approximately to 100% in pancreatic ductal adenocarcinoma56, and that it is closely associated with poor prognosis57. Here, KRAS is linked to pancreatic neoplasm.